CD46 and paroxysmal nocturnal hemoglobinuria: As shown in Fig.5 there are a number of other potential therapeutic targets for complement inhibition, some of which may have a role in treating PNH patients such as C1 inhibitors, C6 Inhibitors, CD46 agonists.